Shingles is a painful condition caused by the virus that also causes chickenpox (varicella-zoster virus , or VZV). It affects about 1 million individuals per year in the United States alone. Shingles, also known as herpes zoster , occurs in persons who have already had chickenpox. Most individuals who develop shingles are older than 50 years, have other medical problems (such as cancer), or are immune-suppressed from medications they take (such as steroid medications). The virus (VZV) causing shingles and chickenpox is a type of herpes virus. It is a different herpes virus from the ones responsible for cold sores or for genital herpes. VZV remains in nerve tissue after a person recovers from chickenpox. The virus remains dormant (inactive) until reactivated to cause shingles. The cause of this reactivation is not completely understood. The January 12, 2011, issue of JAMA includes an article about shingles. This Patient Page is based on one previously published in the July 1, 2009, issue of JAMA.
Rash on one side of the body or the face
Blisters that develop in the rash site and then crust over
Pain, often a tingling-type pain, can occur before the rash appears.
Fever, headache, fatigue, and chills may occur.
Grahic Jump Location
Antiviral medications, if taken soon after symptoms begin, can shorten the length of time a shingles episode lasts. The severity of the episode may also be less if antiviral medications are taken.
Supportive care, including rest and plenty of liquids, is useful in the treatment of shingles (like any other viral infection).
Acetaminophen may help relieve pain and reduce fever, if it is present.
Cover blisters until they are crusted over. Do not scratch blisters, since they can then become infected.
Wash hands frequently.
In rare cases, shingles can be severe and cause critical illness, including pneumonia or encephalitis (inflammation of the brain). Severe episodes of shingles may require hospitalization for more intensive treatment.
Vaccines are available for chickenpox and for shingles. Varicella vaccine (for chickenpox) is recommended for children and for adults who have not already had chickenpox. Shingles vaccine is recommended for adults who are older than 60 years. Certain individuals should not have these vaccines: pregnant women, persons with immune system disease, and infants younger than 12 months.
Persons who have shingles can pass on VZV to others who have not had chickenpox. Once the blisters have healed, the contagious phase is finished.
Some individuals develop a long-lasting pain condition called postherpetic neuralgia after having an episode of shingles. Postherpetic neuralgia is more common in older persons. Early treatment of shingles with an antiviral medication may help prevent postherpetic neuralgia.
Centers for Disease Control and Preventionhttp://www.cdc.gov
World Health Organizationhttp://www.who.int
American Academy of Dermatologyhttp://www.aad.org
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on chickenpox was published in the August 17, 2005, issue.
Sources: Centers for Disease Control and Prevention, World Health Organization, American Academy of Dermatology, National Institute of Neurological Disorders and Stroke, National Institute of Allergy and Infectious Diseases
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.
TOPIC: INFECTIOUS DISEASES
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature Table 9.2-1 Refuted Evidence From Nonhuman Studiesa
Users' Guides to the Medical Literature 1. A 43-year-old woman presents with a painful cluster of vesicles grouped in the T3 dermatome of...
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.